Literature DB >> 33573208

Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in Smokers.

Marta Marin-Oto1, Luis M Seijo2, Miguel Divo3, Gorka Bastarrika4, Ana Ezponda4, Marta Calvo4, Javier J Zulueta1, Guillermo Gallardo5, Elena Cabezas5, German Peces-Barba5, Maria T Pérez-Warnisher2, Jose M Marín6, Bartolomé R Celli3, Ciro Casanova7, Juan P De-Torres8.   

Abstract

BACKGROUND: Pulmonary artery enlargement (PAE) detected using chest computed tomography (CT) is associated with poor outcomes in chronic obstructive pulmonary disease (COPD). It is unknown whether nocturnal hypoxemia occurring in smokers, with or without COPD, obstructive sleep apnoea (OSA) or their overlap, may be associated with PAE assessed by chest CT.
METHODS: We analysed data from two prospective cohort studies that enrolled 284 smokers in lung cancer screening programs and completing baseline home sleep studies and chest CT scans. Main pulmonary artery diameter (PAD) and the ratio of the PAD to that of the aorta (PA:Ao ratio) were measured. PAE was defined as a PAD ≥ 29 mm in men and ≥27 mm in women or as a PA:Ao ratio > 0.9. We evaluated the association of PAE with baseline characteristics using multivariate logistic models.
RESULTS: PAE prevalence was 27% as defined by PAD measurements and 11.6% by the PA:Ao ratio. A body mass index ≥ 30 kg/m2 (OR 2.01; 95%CI 1.06-3.78), lower % predicted of forced expiratory volume in one second (FEV1) (OR 1.03; 95%CI 1.02-1.05) and higher % of sleep time with O2 saturation < 90% (T90) (OR 1.02; 95%CI 1.00-1.03), were associated with PAE as determined by PAD. However, only T90 remained significantly associated with PAE as defined by the PA:Ao ratio (OR 1.02; 95%CI 1.01-1.03). In the subset group without OSA, only T90 remains associated with PAE, whether defined by PAD measurement (OR 1.02; 95%CI 1.01-1.03) or PA:Ao ratio (OR 1.04; 95%CI 1.01-1.07).
CONCLUSIONS: In smokers with or without COPD, nocturnal hypoxemia was associated with PAE independently of OSA coexistence.

Entities:  

Keywords:  COPD; chest CT scan; clinical phenotypes; nocturnal hypoxemia; oximetry; personalised medicine; pulmonary artery enlargement; sleep-disordered breathing

Year:  2021        PMID: 33573208      PMCID: PMC7866508          DOI: 10.3390/jcm10030489

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  34 in total

1.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

2.  Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study.

Authors:  Miguel A Arias; Francisco García-Río; Alberto Alonso-Fernández; Isabel Martínez; José Villamor
Journal:  Eur Heart J       Date:  2006-02-23       Impact factor: 29.983

3.  Pulmonary hypertension in patients with obstructive sleep apnea syndrome.

Authors:  B M Sanner; C Doberauer; M Konermann; A Sturm; W Zidek
Journal:  Arch Intern Med       Date:  1997-11-24

4.  Cigarette Smoke Directly Promotes Pulmonary Arterial Remodeling and Kv7.4 Channel Dysfunction.

Authors:  Javier Sevilla-Montero; David Labrousse-Arias; Cintia Fernández-Pérez; Laura Fernández-Blanco; Bianca Barreira; Gema Mondéjar-Parreño; Elvira Alfaro-Arnedo; Icíar P López; Sandra Pérez-Rial; Germán Peces-Barba; José G Pichel; Víctor Ivo Peinado; Ángel Cogolludo; María J Calzada
Journal:  Am J Respir Crit Care Med       Date:  2021-05-15       Impact factor: 21.405

5.  Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease.

Authors:  Yves Lacasse; Frédéric Sériès; François Corbeil; Marc Baltzan; Bruno Paradis; Paula Simão; Araceli Abad Fernández; Cristóbal Esteban; Miguel Guimarães; Jean Bourbeau; Shawn D Aaron; Sarah Bernard; François Maltais
Journal:  N Engl J Med       Date:  2020-09-17       Impact factor: 91.245

6.  Baseline characteristics of participants in the randomized national lung screening trial.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; Jonathan D Clapp; Kathy L Clingan; Ilana F Gareen; David A Lynch; Pamela M Marcus; Paul F Pinsky
Journal:  J Natl Cancer Inst       Date:  2010-11-22       Impact factor: 13.506

7.  Association of chronic obstructive pulmonary disease and sleep apnea syndrome.

Authors:  A Chaouat; E Weitzenblum; J Krieger; T Ifoundza; M Oswald; R Kessler
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

8.  Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).

Authors:  Tetyana Kendzerska; Richard S Leung; Shawn D Aaron; Najib Ayas; Jacqueline S Sandoz; Andrea S Gershon
Journal:  Ann Am Thorac Soc       Date:  2019-01

9.  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.

Authors: 
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

10.  Pulmonary hypertension in chronic lung disease and hypoxia.

Authors:  Steven D Nathan; Joan A Barbera; Sean P Gaine; Sergio Harari; Fernando J Martinez; Horst Olschewski; Karen M Olsson; Andrew J Peacock; Joanna Pepke-Zaba; Steeve Provencher; Norbert Weissmann; Werner Seeger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.